Bausch Health Companies Inc

Stock Chart, Company Information, and Scan Results

$6.89(as of Jul 31, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bausch Health Companies Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$6.89
Ticker SymbolBHC
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees20,300
CountyUSA
Market Cap$2,576.8M

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc In Our Stock Scanner

As of Aug 02, 2026
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.